Riktkurs.nu
EN | SV
Stockholm Stock Exchange | Mid Cap
Immunovia
+113644.08%
-
Danske Bank

Latest Price Target For Immunovia

Upside:
+113644.08%
AnalystPrice TargetDate
Danske Bank240 SEKSep -21

All Price Targets For Immunovia

AnalystPrice TargetDate
Danske Bank240 SEKSep -21

About The Company

Immunovia AB is a Swedish listed medical technology company. The company develops tools for diagnosing diseases. Blood samples provide biomarker signatures specific to each disease. The first test concerns pancreatic cancer and is now undergoing final validation studies.
Wikipedia